Comment on

• Uterine sarcomas and parasitic myomas after laparoscopic hysterectomy with power morcellation.

  Tan-Kim J, Hartzell KA, Reinsch CS, O'Day CH, Kennedy JS, Menefee SA, Harrison TA. Tan-Kim J, et al. Am J Obstet Gynecol. 2015 May;212(5):594.e1-10. doi: 10.1016/j.ajog.2014.12.002. Epub 2014 Dec 11. Am J Obstet Gynecol. 2015. PMID: 25499259
• Risk of venous thromboembolism in abdominal versus minimally invasive hysterectomy for benign conditions.

  Barber EL, Neubauer NL, Gossett DR. Barber EL, et al. Am J Obstet Gynecol. 2015 May;212(5):609.e1-7. doi: 10.1016/j.ajog.2014.12.006. Epub 2014 Dec 12. Am J Obstet Gynecol. 2015. PMID: 25511239
• Alterations in surgical technique after FDA statement on power morcellation.

  Desai VB, Guo XM, Xu X. Desai VB, et al. Am J Obstet Gynecol. 2015 May;212(5):685-7. doi: 10.1016/j.ajog.2015.02.027. Epub 2015 Feb 28. Am J Obstet Gynecol. 2015. PMID: 25735888 No abstract available.
• Laparoscopic hysterectomy with morcellation vs abdominal hysterectomy for presumed fibroid tumors in premenopausal women: a decision analysis.

  Siedhoff MT, Wheeler SB, Rutstein SE, Geller EJ, Doll KM, Wu JM, Clarke-Pearson DL. Siedhoff MT, et al. Am J Obstet Gynecol. 2015 May;212(5):591.e1-8. doi: 10.1016/j.ajog.2015.03.006. Epub 2015 Mar 24. Am J Obstet Gynecol. 2015. PMID: 25817518 Free PMC article.